Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Current Deferred Revenue (2022 - 2025)

Historic Current Deferred Revenue for Jin Medical International (ZJYL) over the last 4 years, with Q3 2025 value amounting to $495357.0.

  • Jin Medical International's Current Deferred Revenue rose 85654.74% to $495357.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $495357.0, marking a year-over-year increase of 85654.74%. This contributed to the annual value of $495357.0 for FY2025, which is 85654.74% up from last year.
  • Latest data reveals that Jin Medical International reported Current Deferred Revenue of $495357.0 as of Q3 2025, which was up 85654.74% from $346410.0 recorded in Q1 2025.
  • In the past 5 years, Jin Medical International's Current Deferred Revenue registered a high of $830305.0 during Q3 2022, and its lowest value of -$102949.0 during Q3 2023.
  • Moreover, its 4-year median value for Current Deferred Revenue was $495357.0 (2025), whereas its average is $373111.6.
  • Per our database at Business Quant, Jin Medical International's Current Deferred Revenue tumbled by 11239.89% in 2023 and then skyrocketed by 85654.74% in 2025.
  • Jin Medical International's Current Deferred Revenue (Quarter) stood at $830305.0 in 2022, then tumbled by 112.4% to -$102949.0 in 2023, then soared by 36.4% to -$65476.0 in 2024, then surged by 856.55% to $495357.0 in 2025.
  • Its last three reported values are $495357.0 in Q3 2025, $346410.0 for Q1 2025, and -$65476.0 during Q3 2024.